Hence, we speculate that the suppression of inflammatory cell accumulation by adoptive transfer of IL-37 plus TnI–treated tDCs may represent a novel therapeutic strategy for ventricular remodeling after MI in the future. Here, IL37 is linked to myocardial infarction.